The calpain inhibitor MDL28170 induces the expression of apoptotic markers in Leishmania amazonensis promastigotes.
Human cutaneous leishmaniasis is caused by distinct species, including Leishmania amazonensis. Treatment of cutaneous leishmaniasis is far from satisfactory due to increases in drug resistance and relapses, and toxicity of compounds to the host. As a consequence for this situation, the development o...
Main Authors: | Fernanda A Marinho, Keyla C S Gonçalves, Simone S C Oliveira, Diego S Gonçalves, Filipe P Matteoli, Sergio H Seabra, Ana Carolina S Oliveira, Maria Bellio, Selma S Oliveira, Thaïs Souto-Padrón, Claudia M d'Avila-Levy, André L S Santos, Marta H Branquinha |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3909198?pdf=render |
Similar Items
-
Antileishmanial Efficacy of the Calpain Inhibitor MDL28170 in Combination with Amphotericin B
by: Marta H. Branquinha, et al.
Published: (2022-02-01) -
Miltefosine induces programmed cell death in Leishmania amazonensis promastigotes
by: Fernanda de Aquino Marinho, et al.
Published: (2011-06-01) -
MDL28170, a calpain inhibitor, affects Trypanosoma cruzi metacyclogenesis, ultrastructure and attachment to Rhodnius prolixus midgut.
by: Vítor Ennes-Vidal, et al.
Published: (2011-01-01) -
Evaluation of Macroalgae Sulfated Polysaccharides on the Leishmania (L.) amazonensis Promastigote
by: Marcos Hikari Toyama, et al.
Published: (2013-03-01) -
Tocopherol biosynthesis in Leishmania (L.) amazonensis promastigotes
by: José Mário F. Balanco, et al.
Published: (2019-04-01)